“Immune infusions are not a ready-made cocktail but are mixed individually for the patient after a detailed medical history ...

The home infusion industry is experiencing significant growth due to the increasing number of aging patients wanting to ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Jet lag is a common travel nuisance that can turn an exciting journey into an exhausting ordeal. It occurs when there’s a mismatch between your internal body clock and the new time zone you’re in.

The Quadruple Aim—a framework originally rooted in improving patient experience, enhancing population health, and achieving ...

Baxter International plans to exit China’s intravenous fluids market, multiple local media outlets report, citing a letter to ...

IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named one of Fortune’s 100 Fastest Growing Companies for 2024. Iradimed is a leader in the development of innovative magnetic resonance ...

Hurricane Helene wrecked a Baxter International factory that produced 60 percent of the country’s IV fluids. Nearly 25,000 people who need IV nutrition are scrambling.

North Carolina hospitals reeling from Hurricane Helene may soon get some relief from a critical IV fluid shortage ... date on multiple types of intravenous and sterile fluids made by Baxter ...

MaineHealth Franklin Hospital held a ribbon cutting and open house for the newly renovated Cancer Care and IV Therapy center.

Principal treatment-related toxicities that come from amivantamab administration include skin-related reactions, higher risk of venous thrombolism, and infusion-related reactions.

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced the nationwide rollout of its ...